ADR Therapeutics, a subsidiary of Tokyo-based Cytori Cell Research Institute, Inc., has signed a Letter of Intent to collaborate with the King Abdullah International Medical Research Center on a joint clinical trial for a “90-minute complete stem cell therapy.” This partnership aims to foster medical innovation in the Middle East and offer new hope to...
Ayu Life Sciences, a company specializing in medical devices and cell therapy, has announced plans to invest AED 33 million in a new medical manufacturing facility located at the Jebel Ali Free Zone Authority (JAFZA). This investment marks a significant step in enhancing the company’s production capabilities and expanding its footprint in the healthcare sector....
Abu Dhabi has successfully wrapped up a groundbreaking clinical trial, testing a stem cell therapy for knee osteoarthritis. Conducted by the Department of Health – Abu Dhabi (DoH) in partnership with Cellcolabs and Burjeel Holdings, the trial marks a significant step forward in regenerative medicine. The treatment, called StromaForte and developed by Swedish biotech firm...